Rationale: Sepsis induces a sustained immune dysfunction responsible for poor outcome and nosocomial infections. Myeloid-derived suppressor cells (MDSCs) described in cancer and inflammatory processes may be involved in sepsis-induced immune suppression, but their clinical impact remains poorly defined.
Methods: Peripheral blood transcriptomic analysis was performed on 29 patients with sepsis and 15 healthy donors. A second cohort of 94 consecutive patients with sepsis, 11 severity-matched intensive care patients, and 67 healthy donors was prospectively enrolled for flow cytometry and functional experiments.
Measurements and Main Results: Genes involved in MDSC suppressive functions, including S100A12, S100A9, MMP8, and ARG1, were up-regulated in the peripheral blood of patients with sepsis. CD14 pos HLA-DR low/neg monocytic (M)-MDSCs were expanded in intensive care unit patients with and without sepsis and CD14 neg CD15 pos low-density granulocytes/granulocytic (G)-MDSCs were more specifically expanded in patients with sepsis (P , 0.001). Plasma levels of MDSC mediators S100A8/A9, S100A12, and arginase 1 were significantly increased. In vitro, CD14 pos -and CD15 pos -cell depletion increased T-cell proliferation in patients with sepsis. G-MDSCs, made of immature and mature granulocytes expressing high levels of degranulation markers, were specifically responsible for arginase 1 activity. High initial levels of G-MDSCs, arginase 1, and S100A12 but not M-MDSCs were associated with subsequent occurrence of nosocomial infections.
Sepsis is one of the leading causes of admission in intensive care units (ICUs). Despite a decreased overall mortality rate during the past three decades, the prognosis remains hampered by a high long-term mortality secondary to nosocomial infections with opportunistic pathogens or viral reactivations, an increased risk of cardiovascular events and cancers, and frequent hospital readmissions causing increased health care costs (1) (2) (3) (4) . This unfavorable outcome has been largely attributed to a persistent immunologic impairment affecting innate and adaptive immunity (5) . To date, the most described features are (1) monocyte dysfunction illustrated by reduced expression of HLA-DR and impaired production of inflammatory cytokines after bacterial challenge in vitro (6, 7), (2) granulocyte functional impairment (8) , (3) lymphopenia and lymphocyte dysfunction associated with an increased proportion of regulatory T cells (9, 10) , and (4) enhanced systemic indoleamine 2,3-dioxygenase (IDO) activity (11) .
During the past decade, much attention has focused on a heterogeneous population of cells from the myeloid lineage called myeloid-derived suppressor cells (MDSCs), which have been demonstrated to play potent immunosuppressive functions in cancers and inflammatory diseases (12, 13) . In cancer, they are induced by many soluble factors, such as S100A8/A9, granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor (G-CSF), IL-6, IL-10, vascular endothelial growth factor, or transforming growth factor-b) as a consequence of a maturational block and/or dysregulated myelopoiesis. Various mechanisms have been proposed to explain their suppressive activity, including depletion of arginine and tryptophan by arginase 1 and IDO, respectively; production of reactive oxygen species (ROS) by NADPH oxidase; release of IL-10 or transforming growth factor-b; and induction of regulatory T cells (14) (15) (16) (17) . Two main subsets, monocytic (M)-MDSCs and granulocytic (G)-MDSCs, have been identified, but their definition and role in humans remain elusive because of the lack of specific phenotypic markers (18 pos low-density granulocytes (LDGs) that copurify with peripheral blood mononuclear cells (PBMCs) after density gradient centrifugation, were shown to be expanded in patients with sepsis and in ICU patients without sepsis, and to display T-cell inhibitory activity (20) (21) (22) . Especially, CD15
pos LDGs were recently proposed to variably display either arginase or ROS-dependent inhibitory effects with a potential impact of causative pathogens (19, 20) . However, the low number of patients studied and the controversial phenotype and origin of putative suppressor cells preclude any definitive conclusion on the clinical impact, mechanisms of action, and role of MDSCs in patients with sepsis.
Consequently, our objectives were (1) to highlight the various putative MDSC subsets within the circulating myeloid compartment, (2) to characterize their suppressive activity, (3) to clarify their origins, and (4) to study their clinical impact in patients with sepsis.
Methods

Patients and Healthy Donor Participants
This study was performed in the ICU at Rennes University Hospital. A total of 94 consecutive adult patients with sepsis and 11 severity-matched ICU patients without sepsis were prospectively enrolled, and compared with 67 healthy donors. The study design was approved by the local institutional review board and written informed consent was obtained. Pregnant women, patients younger than 18 years old, patients with malignancy, HIV infection, or receiving immunosuppressive agents were excluded. The standard criteria were used for diagnosis of severe sepsis and septic shock (23) . The Simplified Acute Physiology Score, the Sepsis-related Organ Failure Assessment score, and the Logistic Organ Dysfunction system at admission in ICU were used to assess sepsis severity (24) (25) (26) . Patients received standard enteral or parenteral nutrition. The occurrence of nosocomial infections during hospitalization was recorded prospectively and defined as previously described (27) .
Samples
Blood heparinized samples were collected within 3 days following sepsis diagnosis. The delay between sampling and beginning of laboratory procedures was less than 1 hour. PBMCs were isolated by Ficoll density gradient, and plasma samples were stored at 280 8 
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criteria (11) and were stored at 280 8 C before RNA extraction.
Flow Cytometry
White blood cell differentials were obtained using the Cytodiff panel (Beckman Coulter, Brea, CA) (28) . Myeloid subpopulations including MDSCs were then quantified on whole blood or PBMCs using multicolor antibody panels and Flow-count fluorospheres (Beckman Coulter) (see Table E1 in the online supplement). Samples were run on a Navios flow cytometer and data were analyzed using Kaluza software (Beckman Coulter). Gating strategy was defined as previously described ( Figure E1 ) (29) .
Quantitative Real-Time Polymerase Chain Reaction
Quantitative real-time polymerase chain reaction was performed on wholeblood RNA using Taqman array custom microfluidic cards (Applied Biosystems, Foster City, CA) and on purified granulocyte subsets using Fluidigm system. Methods are detailed in the online supplement.
Cytokines and Enzymes Activity Assessment
Plasma levels of myeloperoxidase, neutrophil gelatinase-associated lipocalin (R&D Systems, Minneapolis, MN), S100A8/9, S100A12, and arginase I (Hycult Biotech, Ude, the Netherlands) were determined by ELISA. Plasma levels of G-CSF, IL-10, and IL-12 were measured using a Milliplex map magnetic bead kit (EMD Millipore, Billerica, MA). IDO and arginase activities were respectively evaluated by measuring kynurenine and tryptophan levels by high-performance liquid chromatography, and ornithine and arginine concentrations by ion-exchange chromatography (11, 30) .
Cell Isolation and Culture
Proliferation of T cells from whole or CD14/CD15-depleted PBMCs was assessed by carboxyfluorescein succinimidyl ester (CFSE) dilution. Details are provided in the online supplement. For cytologic analyses, cytospin slides were stained with MayGrünwald-Giemsa.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 6.0 software (San Diego, CA 
Results
Peripheral Blood Transcriptomic Analysis Reveals a Myeloid Suppressive Signature in Patients with Sepsis
A transcriptomic analysis targeting 44 immune-related genes, including cellsubset-specific markers and functional pathways, was conducted on a previously published cohort of 29 patients with sepsis and 15 healthy donors. Unsupervised hierarchical clustering analysis discriminated patients with sepsis from healthy donors ( Figure 1A ). More importantly, genes associated with MDSC recruitment, phenotype, and suppressive functions, including MMP8, MMP9, ARG1, S100A8, S100A9, S100A12, CD274 (programmed death-ligand 1 [PD-L1]), IL4R, and IL10 were upregulated, whereas genes associated with adaptive immunity and inflammation, including CD4, MS4A1 (CD20), CD8B, CD3G, IL8, and IL6 were down-regulated in patients with sepsis (Table 1) . A gene set enrichment analysis confirmed that up-regulated genes were enriched in a large external cohort of patients with sepsis ( Figure 1B ) (32) . Of note, a hierarchical clustering analysis performed among patients with sepsis could not find any segregation according to the severity of illness (i.e., septic shock vs. severe sepsis; see Figure E2 ). ARG1 and S100A9 expression correlated with granulocyte count and inversely correlated with lymphocyte count ( Figure 1C ). Noteworthy, even if both CD247 (CD3z) and CD3G (CD3g) were down-regulated, the CD247/CD3G ratio was further decreased in patients with sepsis and inversely correlated with granulocyte count ( Figure 1D ). Those data raise the hypothesis that a suppressive activity burden by myeloid cells may impair T-cell count and functions in patients with sepsis. To further study the potential role of myeloid cells in sepsis-induced immune dysfunction, we set up an independent prospective cohort of 94 patients with sepsis and 67 healthy donors. The population characteristics are summarized in Table 2 and sepsis etiology is detailed in Table 3 . Because human MDSCs are heterogeneous and poorly defined, we started by performing an extensive description of the circulating myeloid compartment in a cohort of 36 patients with sepsis and 26 healthy donors ( Figure 2A ). As previously described (11) These subsets were not statistically different between patients with severe sepsis and septic shock (data not shown). Importantly, whereas M-MDSC were significantly increased in ICU patients without sepsis (P , 0.001), raising a similar level than in patients with sepsis, G-MDSCs increase was more specific to patients with sepsis ( Figure 2B ) and persisted for at least 14 days ( Figure E3C ). Of note, whereas the proportion of LDGs did not differ according to the Gram staining of the causative microorganism, the number of circulating CD14 pos HLA-DR low/neg monocytes was higher in patients with gram-negative sepsis ( Figure E3D ). Lastly, the three dendritic cell subtype counts (plasmacytoid dendritic cell, and both subsets of myeloid dendritic cell expressing CD1c or CD141) were dramatically decreased in patients with sepsis ( Figure E4A ).
To confirm and extend this work, we studied the characteristic features of MDSC activity at the protein level ( Figure 2C ). In agreement with their increased RNA levels in peripheral blood, concentrations of calcium-binding proteins S100A8/A9 and S100A12 involved in MDSC recruitment (35) were increased in the peripheral blood of patients with sepsis (P , 0.001). Plasma level of G-CSF, which has been reported to take part in the recruitment of G-MDSCs (36), was also increased in patients with sepsis (P = 0.001). The plasma kynurenine/tryptophan ratio reflecting IDO activity was markedly increased in patients with sepsis (0.213 [IQR, 0.092-0.658], 1719%; P , 0.001) compared with healthy donors (0.026; IQR, 0.023-0.035). As previously described, this increase was not associated with an up-regulation of IDO1 expression (data not shown) (11 Figure 3A) . Depletion of CD14 pos cells resulted in a significant increase in the proportion of proliferating CD4 pos (1144%; P = 0.002) and CD8 pos (1124%; P = 0.004) T cells in patients with sepsis, whereas it was associated with a decreased CD4 pos and CD8 pos T-cell proliferation in healthy donors (215%, P = 0.02; 217%, P = 0.008, respectively) ( Figure 3B ; see Figure E5 ). Similarly, depletion of CD15 pos cells in patients with sepsis increased CD4 pos and CD8 pos T-cell proliferation by 160% (P = 0.014) and 165% (P = 0.037), respectively, whereas it had no effect on healthy donor T-cell proliferation, in agreement with the lack of LDGs in normal context. These results indicate that both CD14 pos monocytes, essentially made up of HLA-DR low/neg cells, and CD15 pos LDGs should be considered as MDSCs in sepsis.
We then assessed if sepsis-related MDSCs displayed arginase 1 activity by measuring arginine and ornithine concentrations in culture supernatants. PBMCs from patients with sepsis but not those from healthy donors exerted an arginase 1 activity in vitro, as demonstrated by an increased ornithine/arginine ratio (P = 0.009). This activity was completely abrogated after CD15 pos LDG depletion but was not affected by CD14 pos monocyte depletion (P , 0.001) ( Figure 3C ). In addition, arginase activity strongly correlated with the number of LDGs in culture (r = 0.90; P , 0.001) further reinforcing the demonstration that LDGs, unlike monocytes, are key arginase 1 producers in patients with sepsis.
High Initial Levels of G-MDSC Are Associated with a Higher Risk of Secondary Nosocomial Infections
Among patients with sepsis, 21 (22%) developed one or more nosocomial infection during hospital stay (Table E2) /L] in patients without nosocomial infections; P = 0.046), whereas the mature granulocyte count was not significantly different. A receiver operating characteristic plot determined that LDGs greater than 36% was the best threshold to identify patients with the highest risk of developing nosocomial infections (area under the curve, 0.70; 95% confidence interval, 0.57-0.83). The cumulative incidence of nosocomial infections was thus significantly higher in patients with LDGs greater than 36% (hazard ratio, 2.83; 95% confidence interval, 1.18-8.11; log rank P = 0.023). Conversely, the peripheral CD14 pos HLA-DR low/neg monocyte count was not associated with nosocomial infection occurrence ( Figure 4B ).
In line with those results, development of nosocomial infections was also associated with higher initial plasma concentrations of S100A12 (P = 0.027) and G-CSF (P = 0.013) ( Figure 4C ). More importantly, early levels of arginase 1, specifically produced by G-MDSCs, correlated with initial Sepsis-related Organ Failure Assessment (r = 0.49; P = 0.011, Spearman) and Simplified Acute Physiology Score II (r = 0.41; P = 0.035, Spearman) scores, and were significantly higher in patients who developed nosocomial infections (P = 0.043).
Low-Density Granulocytes in Patients with Sepsis Are Composed of Immature and Mature Granulocytes Expressing High Levels of Degranulation Markers
Given the importance of LDGs in the outcome of patients with sepsis, we finally sought to better characterize them. Detailed phenotypic phenotyping of LDGs revealed high expression of CD11b (aM-integrin, expressed by mice MDSCs) and CD64 (FcgRI, up-regulated on myeloid cells from patients with sepsis), and intermediate levels of CD33 and CD115 (colony-stimulating factor 1 receptor). We also observed two levels of CD16 expression, consistent with mature and immature stages ( Figure E6A ). Box, interquartile range and median; whiskers, range; points, outlying values. Comparisons between groups were performed using Mann-Whitney U test; *P , 0.05, **P , 0.01, ***P , 0.001, ****P , 0.0001. G-CSF = granulocyte colony-stimulating factor; ICU = intensive care unit; IDO = indoleamine 2,3-dioxygenase; Imm Gran = immature granulocytes; Kyn = kynurenin; Mature Gran = mature granulocytes; ns = nonsignificant; Trp = tryptophan.
Because granulocytes that copurify in the PBMC-fraction were called LDGs, we referred to granulocytes that sediment with erythrocytes as high-density granulocytes (HDGs). To determine if LDGs and HDGs could be morphologically and phenotypically distinguished, we compared CD15 pos cells from density gradient interface (LDGs) and pellet (HDGs). Based on their expression of CD16 and CD11b maturation markers, we noticed that LDGs were significantly enriched for immature granulocytes ( Figure 5A) Figure 5B ). Consistently, quantitative real-time polymerase chain reaction performed on paired HDGs/LDGs from five patients with sepsis showed a higher expression of genes involved in early granulocytic maturation in LDGs (CEBPE, CEBPA, and RUNX1) ( Figure 5C ). Because arginase 1 has been previously shown to be stocked inside azurophilic granules of human granulocytes (37), we hypothesized that LDGs might result from neutrophil activation and degranulation. As compared with HDGs, LDGs expressed higher surface levels of CD35 (P , 0.05), CD63 (P , 0.01), and CD66b (P , 0.01) on both mature and immature subsets, indicating degranulation of secretory vesicles, azurophilic, and specific granules, respectively ( Figure 5D ) (38) . Furthermore, LDGs had lower side and forward scatter than HDGs, suggesting that they were smaller and had lower granularity (Figures 5E; see Figure E6B ). Consistently, plasma levels of neutrophil granule proteins myeloperoxidase and neutrophil gelatinase-associated lipocalin were significantly increased in patients with sepsis compared with healthy donors (P , 0.001) ( Figure 5F ). (monocytic MDSC) count was determined by flow cytometry in 36 patients. Among them, nine (25%) developed NI. (C) Plasma levels of S100A12 protein were determined by ELISA in 73 patients, 18 (24.7%) of which developed NI. Plasma levels of granulocyte colony-stimulating factor and arginase 1 enzyme were respectively determined by multiplex Luminex assay and ELISA in 26 patients. Among them, six (23.1%) developed NI. Box, interquartile range and median; whiskers, range; points, outlying values. Comparisons between groups were performed using Mann-Whitney U test. The Mantel-Cox log-rank test was used to compare the Kaplan-Meier curves. *P , 0.05; **P , 0.01. G-CSF = granulocyte colony-stimulating factor; ns = nonsignificant.
Discussion
Most patients surviving the initial phase of sepsis display signs of immune suppression directly related to persistent lymphopenia and T-cell exhaustion (39, 40) . In this study, we demonstrated that CD14 pos HLA-DR low/neg M-MDSCs were expanded in ICU patients with and without sepsis and that CD14 neg CD15
pos LDGs/G-MDSCs were more specifically expanded in patients with sepsis. Both subsets independently inhibited T-cell proliferation in vitro. Especially, G-MDSCs responsible for an arginase activity were composed of immature and mature granulocytes displaying high levels of degranulation markers. More importantly, we demonstrated that the early expansion of G-MDSC predicted the development of nosocomial infections in patients with sepsis.
Of note, our conclusions were based on a single center exploratory study. Despite the relatively large number of patients included, the design and the number of events did not allow to perform a reliable multivariate analysis of risk factors associated with ICU-acquired infections. A multicentric study will allow confirming the specific role of G-MDSCs in the promotion of nosocomial infections in patients with sepsis.
The decreased expression of HLA-DR on monocytes has been associated with poor prognosis and increased risk of nosocomial infections, and is currently considered an essential surrogate marker of monocyte unresponsiveness (41) . "Endotoxin tolerance," defined by the reduced capacity of monocytes to release proinflammatory cytokines associated with a preserved or enhanced ability to release antiinflammatory mediators in response to bacterial compounds, has thus been one of the most described features of sepsisinduced immunosuppression (42) . For the first time, we described CD14 further developed nosocomial infections. This result could be explained by the fact that only persisting but not initial low monocyte HLA-DR expression predicts mortality in septic shock (7, 43) . Moreover, we demonstrated that expansion of M-MDSC was not specific to patients with sepsis and could reflect a more global response to injury in ICU patients. As described in mice, stress-induced endogenous production of cortisol, and corticosteroid medications, could be involved in this process (44) . Consequently, the precise role of those cells during immune response and their mechanisms of action deserves to be further described.
Besides M-MDSCs, granulocyte subsets also seem to display potent suppressive functions during sepsis. To date, neutrophils had been mainly shown to be affected by a severe dysfunction, including impaired capacities of bacterial clearance, reduced production of ROS, and decreased recruitment to infected tissues (45) . Patients with the most severe dysfunction were more vulnerable to nosocomial infections (8) . As recently reported, we found a high proportion of LDGs/G-MDSCs in patients with sepsis compared with healthy donors (19, 20, 46) . Moreover, we revealed for the first time that this increase in G-MDSC was much stronger in patients with sepsis than in severity-matched ICU patients without sepsis and should thus be considered as a more specific feature of the septic immune microenvironment. G-MDSCs were specifically responsible for an arginase activity. They were associated with a decreased CD3z chain expression, and were directly able to inhibit T-cell proliferation. Unlike previously described, we did not find any association with the Gram staining of the causative organism (19) . This discrepancy may be explained by the larger size of our cohort, reflecting a higher diversity of infections. Arginase is one of the most described mechanisms of MDSC-mediated suppression (16) . However, we cannot exclude that other mechanisms, such as ROS production or PD-L1 expression, could also be involved in patients with sepsis. In agreement, arginase 1 inhibition failed to restore T-cell proliferation in vitro (data not shown) and CD274/PD-L1 expression was increased in the peripheral blood of patients with sepsis.
Although LDGs have been described as a unique population of granulocytes that copurify with PBMCs after density centrifugation, their origins in patients with sepsis remained unclear. We demonstrated that G-MDSC consisted of both immature and mature cells displaying high levels of degranulation markers. As previously described, the immature subset may originate from the bone marrow as a result of emergency myelopoiesis (47) . Consistently, we found high levels of G-CSF in the plasma from patients with sepsis. Thus, simultaneously to the reconstitution and expansion of the primary granulocytic compartment, development of G-MDSCs may represent an important mechanism of regulation of the immune response.
Accordingly, a recent prospective immunomonitoring study revealed that circulating immature granulocytes predicted early sepsis deterioration and could be responsible for immunosuppression through the induction of T-cell lymphopenia (21) . Besides this process of increased myelopoiesis, animal studies strongly suggest the existence of an early disruption of myeloid maturation and differentiation (47, 48 (49, 50) . Conversely, in a mouse tumor model, Sagiv and colleagues (51) demonstrated that mature LDGs may also derive from HDGs on transforming growth factor-b stimulation but not by a degranulation process, suggesting a high diversity and plasticity of granulocytes, depending on various pathologic processes.
Importantly, we demonstrated that a high level of G-MDSCs at the initial phase of sepsis predicted the development of subsequent nosocomial infections in medical-ICU patients with sepsis. Arginase 1 produced by G-MDSCs plays a major role in the plasma arginine depletion (the socalled arginine-deficiency syndrome [52] ) and the subsequent poor prognosis, as previously described in ICU patients without sepsis (22) . Granulocytes that have been considered for a long while as primary short-lived effectors of the host defense seem to display an important plasticity during sepsis. The massive recruitment of neutrophils from the bone marrow combined with a delayed apoptosis results in a markedly increased number of circulating neutrophils of various degrees of maturation (53, 54) . Pathogen-derived factors and endogenous alarmins, such as S100 proteins, may subsequently promote polarization of specific subpopulations toward suppressive phenotypes. Of note, MDSC counts were not significantly different between survivors and nonsurvivors (data not shown). This result might be explained by the important decrease in sepsis mortality during the past decades (1). Moreover, a large prospective observational study recently demonstrated that ICUacquired infections contributed only ) in paired LDGs and HDGs was compared (ratio of the mean expression in LDGs to the mean expression in HDGs). (D and E) LDGs express high levels of degranulation markers. Mean fluorescence intensity of degranulation surface markers (CD35, CD63, CD66b), size (forward scatter), and granularity (side scatter) were compared by flow cytometry between LDGs and HDGs purified from nine patients with sepsis. Box, interquartile range and median; whiskers, range; points, outlying values. Wilcoxon matched-pairs signed rank test; *P , 0.05, **P , 0.01. (F) Plasma levels of neutrophil granule proteins are increased in patients with sepsis. Plasma levels of myeloperoxidase and neutrophil gelatinase-associated lipocalin were determined by ELISA in 16 healthy donors and 74 patients with sepsis. Box, interquartile range and median; whiskers, range; points, outlying values. Mann-Whitney U test; ****P , 0.0001. FS = forward scatter; HD = healthy donors; M = myelocytes; MFI = mean fluorescence intensity; MM = metamyelocytes; MPO = myeloperoxidase; NGAL = neutrophil gelatinase-associated lipocalin; PM = promyelocytes; PMN = polymorphonuclear cells; Se = sepsis; SS = side scatter. modestly to overall mortality (55) . Consequently, occurrence of nosocomial infections might be a more relevant endpoint than overall mortality regarding consequences of sepsis-induced immunosuppression.
Conclusions
Altogether, our results show that MDSCs are major actors of the sepsis-induced immune suppression. CD14 pos HLA-DR low/neg M-MDSCs and CD15 pos G-MDSCs strongly contribute to T-cell dysfunction in patients with sepsis and the early expansion of arginase-1-producing G-MDSCs specifically promotes the development of nosocomial infections. Controlling the expansion of MDSCs or blocking their suppressive functions may represent promising novel therapeutic approaches in sepsis, as currently developed for cancer (56) (57) (58) . n Author disclosures are available with the text of this article at www.atsjournals.org.
